Skip to main content

Table 2 Relationship between Dietary Intake of Fatty Acids and Respiratory Symptoms in U.S. Adults with COPD

From: Omega-3 fatty acid intake and prevalent respiratory symptoms among U.S. adults with COPD

 

Alpha-linolenic acid (ALA)

Linoleic Acid (LA)

Interaction (ALA*LA)

OR (95% CI)

p-val

OR (95% CI)

p-val

OR (95% CI)

pint

Chronic Cough

0.60 (0.36-0.99)

0.045

1.005 (0.97-1.04)

0.781

1.02 (1.00-1.04)

0.015

Nocturnal Cough

0.84 (0.42-1.69)

0.628

1.040 (0.96-1.13)

0.353

1.02 (1.00-1.03)

0.053

Phlegm

0.83 (0.51-1.35)

0.437

1.000 (0.95-1.05)

1.000

1.01 (0.99-1.03)

0.096

Wheeze (any)

0.63 (0.41-0.98)

0.039

1.014 (0.97-1.06)

0.510

1.02 (1.00-1.03)

0.037

Nocturnal Wheeze

0.78 (0.42-1.44)

0.420

1.003 (0.95-1.06)

0.921

1.02 (1.00-1.03)

0.032

Wheeze with Exertion

0.81 (0.38-1.69)

0.563

1.003 (0.95-1.06)

0.916

1.02 (0.99-1.04)

0.106

Meds for Wheeze

0.46 (0.22-0.94)

0.034

1.089 (1.02-1.16)

0.008

0.99 (0.96-1.03)

0.729

  1. Adjusted for age, gender, race, education, smoking status, FEV1, total calories, BMI, pack per years ALA and LA levels are centered at mean levels for the NHANES population (age 40–79)